SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19Nina Kreuzberger, Nicole Skoetz, Lise J Estcourt et al.|Cochrane Database of Systematic Reviews|2021Cited by 152
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19Caroline Hirsch, Nina Kreuzberger, Sarah J Valk et al.|Cochrane Database of Systematic Reviews|2021Cited by 19
Informing pandemic management in Germany with trustworthy living evidence syntheses and guideline development: lessons learned from the COVID-19 evidence ecosystemAngela Kunzler, Joerg J Meerpohl, Claire Iannizzi et al.|Journal of Clinical Epidemiology|2024Cited by 6
Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19'Nina Kreuzberger, Nicole Skoetz, Caroline Hirsch et al.|Zenodo (CERN European Organization for Nuclear Research)|2021Cited by 0
Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19'Nina Kreuzberger, Nicole Skoetz, Caroline Hirsch et al.|Figshare|2021Cited by 0